Divi's Laboratories Ltd.

•

divislabs.comBSE: 532488NSE: DIVISLAB

Market Cap₹ 2,47,576 Cr.

Current Price

High / Low₹ 9,615 / 5,636

Stock P/E84.2

Book Value₹ 663

Price to Book9.43

Dividend Yield0.32 %

ROCE21.9 %

ROE16.5 %

Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Latest quarter profit grew 60.0% YoY, showing strong momentum
Company has been maintaining a healthy dividend payout of 30.5%
Company has a consistent dividend-paying track record
Company generates healthy free cash flow

CONS

Stock is trading at 9.4x its book value
Company has delivered a poor profit growth of 5.9% over past five years
Expensive relative to growth - PEG of 6.5
Rich enterprise valuation - EV/EBITDA of 38.6x

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY NEXT 50 NIFTY PHARMA NIFTY100 QUALTY30 NIFTYLARGEMIDCAP250 NIFTY100 EQL WGT

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	BIOCON	390.95	128.63	63712.89	0.13	136.80	53.36	4336.00	10.89	3.26	19.54

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	1,730	1,868	1,808	2,259	2,063	2,302	2,297	2,536	2,357	2,660	2,578	2,793	2,974
	1,239	1,394	1,317	1,542	1,442	1,573	1,550	1,655	1,614	1,765	1,671	1,850	1,872
Operating Profit	491	474	491	717	621	729	747	881	743	895	907	943	1,102
OPM %	28.38%	25.37%	27.16%	31.74%	30.10%	31.67%	32.52%	34.74%	31.52%	33.65%	35.18%	33.76%	37.05%
	80	85	94	79	79	105	82	87	119	146	13	154	63
Interest	0	1	0	2	0	1	0	0	3	8	6	6	6
Depreciation	93	94	95	94	97	98	99	107	112	113	116	120	132
Profit before Tax	478	464	490	700	603	735	730	861	747	920	798	971	1,165
Tax %	27.82%	26.29%	26.94%	24.14%	28.69%	29.52%	18.63%	22.53%	25.44%	24.35%	25.06%	22.14%	23.52%
Net Profit	345	342	358	531	430	518	594	667	557	696	598	756	891
	12.99	12.89	13.50	19.99	16.18	19.51	22.39	25.12	20.95	26.24	22.56	28.44	33.55

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	4,024	3,816	4,880	5,311	6,799	8,880	7,625	7,665	9,198	10,388	11,005
	2,585	2,564	3,030	3,494	3,978	5,005	5,276	5,490	6,218	6,899	7,158
Operating Profit	1,439	1,252	1,850	1,816	2,821	3,875	2,349	2,175	2,980	3,489	3,847
OPM %	35.76%	32.80%	37.91%	34.20%	41.49%	43.64%	30.81%	28.38%	32.40%	33.59%	34.96%
	76	112	157	190	63	114	349	337	352	432	376
Interest	3	2	5	7	2	2	2	4	2	24	26
Depreciation	123	142	169	186	255	311	342	376	401	461	481
Profit before Tax	1,388	1,219	1,833	1,813	2,628	3,677	2,354	2,132	2,929	3,436	3,854
Tax %	24.13%	28.69%	27.31%	24.30%	25.62%	19.80%	23.19%	26.08%	24.58%	24.13%	23.69%
Net Profit	1,053	870	1,333	1,373	1,955	2,949	1,808	1,576	2,209	2,607	2,941
EPS	39.68	32.76	50.20	51.71	73.63	111.07	68.11	59.47	83.36	98.38	—
Dividend Payout %	25.20%	30.53%	31.87%	30.94%	27.16%	27.01%	43.97%	50.44%	35.99%	30.49%	—

COMPOUNDED SALES GROWTH

10 Years:: 11%
5 Years:: 9%
3 Years:: 11%

COMPOUNDED PROFIT GROWTH

10 Years:: 9%
5 Years:: 6%
3 Years:: 13%

STOCK PRICE CAGR

10 Years:: 22%
5 Years:: 13%
3 Years:: 35%
1 Year:: 55%

RETURN ON EQUITY

10 Years:: 19%
5 Years:: 17%
3 Years:: 15%
Last Year:: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	53	53	53	53	53	53	53	53	53	53
	5,356	5,907	6,920	7,264	9,218	11,638	12,652	13,431	14,842	16,658
	36	63	106	34	0	0	0	0	2	674
Trade Payables	442	406	483	580	749	771	743	807	880	1,190
	1,597	1,942	1,237	1,477	1,319	2,104	1,336	1,542	1,839	2,239
Total Liabilities	7,484	8,370	8,800	9,408	11,340	14,567	14,784	15,833	17,616	20,814
	1,559	1,996	2,087	2,776	3,699	4,321	4,719	4,737	5,440	6,520
Capital Work in Progress	444	120	492	920	711	470	212	778	1,022	2,113
	1,639	1,897	1,953	979	7	79	84	89	72	76
	1,256	1,281	1,663	1,744	2,043	2,644	2,781	2,985	3,033	3,711
	0	0	0	0	0	0	0	2,273	2,855	3,228
Cash & Bank	66	91	105	107	2,142	2,804	4,188	3,961	3,696	3,371
	2,520	2,985	2,499	2,882	2,738	4,249	2,800	1,010	1,498	1,795
Total Assets	7,484	8,370	8,800	9,408	11,340	14,567	14,784	15,833	17,616	20,814

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1,451	1,033	1,447	1,654	2,580	2,540	2,919	1,266	1,650	2,711
Cash from Investing	-1,137	-476	-684	-81	75	-2,195	-2,707	-268	-803	-2,218
Cash from Financing	3	-314	-246	-1,091	-34	-532	-796	-798	-797	-802
	15	-25	34	36	1,988	-817	-1,056	200	50	-309

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	51.90	51.89	51.89	51.89	51.89	51.89	51.88	51.88	51.88
	16.16	17.25	17.98	18.01	19.74	19.39	20.08	20.29	20.19
	21.66	20.98	20.44	20.63	18.96	19.68	19.18	19.13	19.29
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	10.18	9.80	9.59	9.39	9.32	8.96	8.76	8.60	8.54

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-12

Copy of Newspaper Publication

2026-09-12 - Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-10

Shareholders meeting

2026-08-10 - Divi's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 10, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.

2026-08-06

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-06 - Divi's Laboratories Limited has informed the Exchange about Transcript

2026-08-03

Copy of Newspaper Publication

2026-08-03 - Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-01

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-01 - Divi's Laboratories Limited has informed the Exchange about Link of Recording

2026-08-01

Change in Management

2026-08-01 - Divi's Laboratories Limited has informed the Exchange about change in Senior Management.

2026-08-01

Outcome of Board Meeting

2026-08-01 - Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-31

Retirement

2026-07-31 - Divi's Laboratories Limited has informed the Exchange about Retirement of Senior Management Personnel.

2026-07-24

Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-24 - Divi's Laboratories Limited has informed the Exchange about Schedule of meet

News

Recent coverage and analyst commentary for DIVISLAB

Loading news…

🤖

AI Stock Analyst

Divi's Laboratories Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

BIOCON

390.95

128.63

63712.89

0.13

136.80

53.36

4336.00

10.89

3.26

19.54

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

1,730

1,868

1,808

2,259

2,063

2,302

2,297

2,536

2,357

2,660

2,578

2,793

2,974

1,239

1,394

1,317

1,542

1,442

1,573

1,550

1,655

1,614

1,765

1,671

1,850

1,872

Operating Profit

491

474

491

717

621

729

747

881

743

895

907

943

1,102

OPM %

28.38%

25.37%

27.16%

31.74%

30.10%

31.67%

32.52%

34.74%

31.52%

33.65%

35.18%

33.76%

37.05%

105

119

146

154

Interest

Depreciation

107

112

113

116

120

132

Profit before Tax

478

464

490

700

603

735

730

861

747

920

798

971

1,165

Tax %

27.82%

26.29%

26.94%

24.14%

28.69%

29.52%

18.63%

22.53%

25.44%

24.35%

25.06%

22.14%

23.52%

Net Profit

345

342

358

531

430

518

594

667

557

696

598

756

891

12.99

12.89

13.50

19.99

16.18

19.51

22.39

25.12

20.95

26.24

22.56

28.44

33.55

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

4,024

3,816

4,880

5,311

6,799

8,880

7,625

7,665

9,198

10,388

11,005

2,585

2,564

3,030

3,494

3,978

5,005

5,276

5,490

6,218

6,899

7,158

Operating Profit

1,439

1,252

1,850

1,816

2,821

3,875

2,349

2,175

2,980

3,489

3,847

OPM %

35.76%

32.80%

37.91%

34.20%

41.49%

43.64%

30.81%

28.38%

32.40%

33.59%

34.96%

112

157

190

114

349

337

352

432

376

Interest

Depreciation

123

142

169

186

255

311

342

376

401

461

481

Profit before Tax

1,388

1,219

1,833

1,813

2,628

3,677

2,354

2,132

2,929

3,436

3,854

Tax %

24.13%

28.69%

27.31%

24.30%

25.62%

19.80%

23.19%

26.08%

24.58%

24.13%

23.69%

Net Profit

1,053

870

1,333

1,373

1,955

2,949

1,808

1,576

2,209

2,607

2,941

EPS

39.68

32.76

50.20

51.71

73.63

111.07

68.11

59.47

83.36

98.38

—

Dividend Payout %

25.20%

30.53%

31.87%

30.94%

27.16%

27.01%

43.97%

50.44%

35.99%

30.49%

—

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

5,356

5,907

6,920

7,264

9,218

11,638

12,652

13,431

14,842

16,658

106

674

Trade Payables

442

406

483

580

749

771

743

807

880

1,190

1,597

1,942

1,237

1,477

1,319

2,104

1,336

1,542

1,839

2,239

Total Liabilities

7,484

8,370

8,800

9,408

11,340

14,567

14,784

15,833

17,616

20,814

1,559

1,996

2,087

2,776

3,699

4,321

4,719

4,737

5,440

6,520

Capital Work in Progress

444

120

492

920

711

470

212

778

1,022

2,113

1,639

1,897

1,953

979

1,256

1,281

1,663

1,744

2,043

2,644

2,781

2,985

3,033

3,711

2,273

2,855

3,228

Cash & Bank

105

107

2,142

2,804

4,188

3,961

3,696

3,371

2,520

2,985

2,499

2,882

2,738

4,249

2,800

1,010

1,498

1,795

Total Assets

7,484

8,370

8,800

9,408

11,340

14,567

14,784

15,833

17,616

20,814

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

1,451

1,033

1,447

1,654

2,580

2,540

2,919

1,266

1,650

2,711

Cash from Investing

-1,137

-476

-684

-81

-2,195

-2,707

-268

-803

-2,218

Cash from Financing

-314

-246

-1,091

-34

-532

-796

-798

-797

-802

-25

1,988

-817

-1,056

200

-309

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

51.90

51.89

51.88

16.16

17.25

17.98

18.01

19.74

19.39

20.08

20.29

20.19

21.66

20.98

20.44

20.63

18.96

19.68

19.18

19.13

19.29

Government

0.00

10.18

9.80

9.59

9.39

9.32

8.96

8.76

8.60

8.54

Divi's Laboratories Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Divi's Laboratories Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI